Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01839695 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Valiant Mona LSA Stent Graft System
A NA study, sponsored by Medtronic Cardiovascular.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT01839695: Completed NA study, sponsored by Medtronic Cardiovascular.
NCT01839695 is a NA study that has completed, run by Medtronic Cardiovascular. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01839695, a NA study, has completed, sponsored by Medtronic Cardiovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The Valiant Mona LSA thoracic stent graft system is for the endovascular repair of aneurysms of the descending thoracic aorta (DTA) in patients who require coverage of the left subclavian artery (LSA).The study is intended to assess safety and performance of the device acutely and at 30 days.
Primary Outcome
Major Adverse Events is a composite endpoint that includes Aneurysm Related Mortality (ARM), Stroke, Paraplegia, and Left Arm/Hand Ischemia.
Interventions
- DEVICE Valiant Mona LSA Stent Graft System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-04 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT01839695 record still lists
NCT01839695 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Valiant Mona LSA Stent Graft System is the first listed.
NCT01839695 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01839695 about?
NCT01839695 is a clinical study titled "Safety and Efficacy of Valiant Mona LSA Stent Graft System". The Valiant Mona LSA thoracic stent graft system is for the endovascular repair of aneurysms of the descending thoracic aorta (DTA) in patients who require coverage of the left subclavian artery (LSA).The study is intended to assess safety and performance of the device acutely and at 30 days.
What is the current status of trial NCT01839695?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2013-04. Estimated completion is 2018-12.
What interventions are being tested in trial NCT01839695?
The interventions under investigation include: Valiant Mona LSA Stent Graft System (DEVICE).
Who is sponsoring clinical trial NCT01839695?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01839695's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia